PHP
TECX

Parkman Healthcare Partners’s Tectonic Therapeutic TECX Stock Holding History

Parkman Healthcare Partners’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,085
Closed -$1.69M – 98
2020
Q4 		$1.69M Sell
10,085
-3,300
-25% -$587K 0.43% 61
2020
Q3 		$2.09M Sell
13,385
-2,498
-16% -$503K 0.55% 58
2020
Q2 		$3.33M Sell
15,883
-8,750
-36% -$1.8M 0.94% 39
2020
Q1 		$4.6M Buy
24,633
+17,133
+228% +$4.04M 2.13% 13
2019
Q4 		$1.81M Buy
+7,500
New +$1.45M 0.52% 54

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Parkman Healthcare Partners's TECX Position: Q1 2021 in Review

Parkman Healthcare Partners sold out of Tectonic Therapeutic (TECX) in Q1 2021, closing a stake of 10,085 shares — an estimated $1.69M sold.

Parkman Healthcare Partners first reported a position in TECX in Q4 2019 and held it in 5 quarters. The position peaked at $4.6M in Q1 2020. 99 funds tracked by Wall St. Rank hold TECX as of Q1 2021.

  • Parkman Healthcare Partners reported no remaining Tectonic Therapeutic position as of Q1 2021 after selling out during the quarter.
  • Parkman Healthcare Partners sold 10,085 Tectonic Therapeutic shares in Q1 2021, an estimated $1.69M.
  • Parkman Healthcare Partners first reported a position in Tectonic Therapeutic in Q4 2019 and held it in 5 quarters.
  • Parkman Healthcare Partners's Tectonic Therapeutic position peaked at $4.6M in Q1 2020.
  • 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2021.

Based on Parkman Healthcare Partners's 13F filing for Q1 2021, filed 14 May 2021.